Harrisburg, NC -- (SBWIRE) -- 10/11/2018 -- Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease (ESRD) patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the number of organ donors is increasing, an increase in transplant procedures is bound to happen. However, due to costlier procedure the market shift is expected to occur in Asian countries where medical tourism is being promoted.
Kidney Transplant Performed Analysis: United States is the leading kidney transplant performed with more than 40% share in 2015. The number of Kidney transplant done in 10 countries covered in the report was more than 40 Thousand in 2015. Brazil is the second leading kidney transplant performed country with more than 10% share. United Kingdom stands at the 3rd position in kidney transplant number. France and Mexico stand at the 4th and 5th place respectively in 2015.
Buy complete research data at:
Kidney Transplant Market Analysis: United States is the leading market for kidney transplant in 10 countries covered being followed by France. Spain stands at the 3rd position followed by Germany. Japan and Italy are competing very closely with each other to capture the maximum market share.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides the number of kidney transplant, as well as market and market shares of Kidney Transplant market. The report entails major organ transplant (immunosuppressant) drug sales analysis. This report also covers key development, drivers and challenges of Kidney Transplant market.
The 10 countries covered in the report are analysed from two viewpoints:
1. Number of Kidney Transplant Performed (2008 - 2021)
2. Kidney Transplant Market (2008 - 2021)
For More Details Inquire at:
Based on geographical distribution, the Kidney Transplant market is categorized into following sub-markets:
1. United States
5. United Kingdom
Organ Transplantation Immunosuppressive/Rejection Drugs Analysis in the report are as follows
1. Cellcept (Mycophenolate Mofetil)
3. Rapamune (Sirolimus)
4. Myfortic (Mycophenolic Acid)
5. Neoral / Sandimmune (Cyclosporine)
6. Zortress / Certican (Everolimus)
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Browse Full Report at:
Reasons to Purchase this Report
- Identify the current and future prospect of the Kidney Transplant market in the developed and emerging markets
- Analyze various perspectives of the market with the help of Porter's five forces analysis
- Information about the growth of the various material, type, and application that are expected to dominate the market
- Regional and country analysis of the market
- Identify the latest developments, market shares, and strategies employed by the major market players
- 3 months analyst support, along with the Market Estimate sheet (in Excel)
About Us: -
MarketInsightsReports provides syndicated market research reports to industries, organizations or even individuals with an aim of helping them in their decision making process. These reports include in-depth market research studies i.e. market share analysis, industry analysis, information on products, countries, market size, trends, business research details and much more. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
+1 (704) 266-3234 |firstname.lastname@example.org
Connect with us on: